Literature DB >> 32237918

Chloroquine and hydroxychloroquine to treat COVID-19: between hope and caution.

Bruno Mégarbane1.   

Abstract

Entities:  

Year:  2020        PMID： 32237918     DOI： 10.1080/15563650.2020.1748194

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN： 1556-3650            Impact factor:   4.467


× No keyword cloud information.
  12 in total

1.  Management strategies for patients with autoimmune diseases during the COVID-19 pandemic: A perspective from China.

Authors:  Yu Liu; Christopher Chang; Qianjin Lu
Journal:  Eur J Rheumatol       Date:  2020-04-10

2.  Case Report: Hepatotoxicity Associated with the Use of Hydroxychloroquine in a Patient with COVID-19.

Authors:  Melissa Barreto Falcão; Luciano Pamplona de Góes Cavalcanti; Nivaldo Menezes Filgueiras Filho; Carlos Alexandre Antunes de Brito
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

Review 3.  Hydroxychloroquine and Chloroquine in Prophylaxis and Treatment of COVID-19: What Is Known?

Authors:  Pathiyil Ravi Shankar; Subish Palaian; Shabaz Mohiuddin Gulam
Journal:  J Pharm Bioallied Sci       Date:  2020-10-06

Review 4.  Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases.

Authors:  Dorothy H J Cheong; Daniel W S Tan; Fred W S Wong; Thai Tran
Journal:  Pharmacol Res       Date:  2020-05-13       Impact factor: 7.658

Review 5.  The clinical benefits of Chinese patent medicines against COVID-19 based on current evidence.

Authors:  Dan Zhang; Bing Zhang; Jin-Tao Lv; Ri-Na Sa; Xiao-Meng Zhang; Zhi-Jian Lin
Journal:  Pharmacol Res       Date:  2020-05-05       Impact factor: 7.658

Review 6.  Gut Microbiota Dysbiosis-Immune Hyperresponse-Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches.

Authors:  Carolina Ferreira; Sofia D Viana; Flávio Reis
Journal:  Microorganisms       Date:  2020-10-01

Review 7.  Chloroquine against malaria, cancers and viral diseases.

Authors:  Wenmin Zhou; Hui Wang; Yuqi Yang; Zhe-Sheng Chen; Chang Zou; Jianye Zhang
Journal:  Drug Discov Today       Date:  2020-09-16       Impact factor: 7.851

8.  Clinical data mining reveals Gancao-Banxia as a potential herbal pair against moderate COVID-19 by dual binding to IL-6/STAT3.

Authors:  Weikang Luo; Ruoqi Ding; Xiaohang Guo; Tao Zhan; Tao Tang; Rong Fan; Yang Wang
Journal:  Comput Biol Med       Date:  2022-03-26       Impact factor: 6.698

Review 9.  An overview of possible solutions putting an end to the COVID-19 pandemic.

Authors:  Saina Adiban Afkham; Amirhossein Hessami; Amene Saghazadeh; Nima Rezaei
Journal:  Acta Biomed       Date:  2022-05-11

10.  Hydroxychloroquine hitting the headlines-retinal considerations.

Authors:  Susan M Downes; Bart P Leroy; Srilakshmi M Sharma; Sobha Sivaprasad; Hélène Dollfus
Journal:  Eye (Lond)       Date:  2020-05-19       Impact factor: 4.456
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.